Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The metabolic basis of kidney cancer.

Seminars in cancer biology - 1 Feb 2013

Linehan W Marston, Ricketts Christopher J

Abstract excerpt

Kidney cancer is not a single disease; it is made up of a number of different types of cancer that occur in the kidney. Each of these different types of kidney cancer can have a different histology, have a different clinical course, can respond differently to therapy and is caused by a different gene. Kidney cancer is essentially a metabolic disease; each of the known genes for kidney cancer, VHL, MET, FLCN,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Basic Helix-Loop-Helix Leucine Zipper Transcription Factors
Share to Carcinoma, Renal Cell
Share to Citric Acid Cycle

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Kidney Neoplasms

Share to Proto-Oncogene Proteins

Share to Tuberous Sclerosis

Share to Tumor Suppressor Proteins

Share to Von Hippel-Lindau Tumor Suppressor Protein

Source

Open in PubMed Open full text

Identifiers

PMID: 22705279
DOI: 10.1016/j.semcancer.2012.06.002
PMCID: PMC3563773

Genes

FLCN
MET
MITF
PTEN
SDHB
SDHD
TFEB
TSC1
TSC2
VHL

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The metabolic basis of kidney cancer.PMID 22705279Read ↗

The genetic basis of kidney cancer: a metabolic disease.Semantic proximity Read ↗

Genetic basis of kidney cancer: role of genomics for the development of disease-based therapeutics.Semantic proximity Read ↗

The molecular code of kidney cancer: A path of discovery for gene mutation and precision therapy.Semantic proximity Read ↗

Metabolic alterations in hereditary and sporadic renal cell carcinomaSemantic proximity Read ↗

BHD-associated kidney cancer exhibits unique molecular characteristics and a wide variety of variants in chromatin remodeling genesSemantic proximity Read ↗

Advances in Molecular Mechanisms of Kidney Disease: Integrating Renal Tumorigenesis of Hereditary Cancer Syndrome.Semantic proximity Read ↗

The Complex Interplay between Metabolic Reprogramming and Epigenetic Alterations in Renal Cell CarcinomaSemantic proximity Read ↗

Genomic alterations and diagnosis of renal cancerSemantic proximity Read ↗

Functional deficiency of succinate dehydrogenase promotes tumorigenesis and development of clear cell renal cell carcinoma through weakening of ferroptosisSemantic proximity Read ↗

Genetic predisposition to kidney cancer.Semantic proximity Read ↗

Metabolic reprogramming in polycystic kidney disease and other renal ciliopathiesSemantic proximity Read ↗

Papillary renal cell carcinomas rewire glutathione metabolism and are deficient in anabolic glucose synthesisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.